Turning Point Therapeutics Revenue Growth Rates (TPTX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Turning Point Therapeutics Inc.  (NASDAQ: TPTX)
 

TPTX's Revenue Growth by Quarter and Year

Turning Point Therapeutics's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TPTX Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.12
1st Quarter March 0.43
FY 0.55





TPTX Revenue second quarter 2022 Y/Y Growth Comment
Turning Point Therapeutics Inc. reported drop in Revenue in the second quarter 2022 by -97.69% to $ 0.12 millions, from the same quarter in 2021.
Despite modest results in the second quarter 2022, contraction in Turning Point Therapeutics Inc.'s Revenue appears to be smaller than Company's recent average decline.

Looking into second quarter 2022 results within Major Pharmaceutical Preparations industry 267 other companies have achieved higher Revenue growth. While Turning Point Therapeutics Inc.' s Revenue meltdown of -97.69% ranks overall at the positon no. 4040 in the second quarter 2022.


TPTX Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter December - - - -
3rd Quarter September - -98.16 % - -
2nd Quarter June -97.69 % - - -
1st Quarter March -98.29 % - - -
FY   - 23.32 % - -

Financial Statements
Turning Point Therapeutics's second quarter 2022 Revenue $ 0.12 millions TPTX's Income Statement
Turning Point Therapeutics's second quarter 2021 Revenue $ 5.16 millions Quarterly TPTX's Income Statement


TPTX Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter December - - - -
3rd Quarter September - -91.09 % - -
2nd Quarter June -72.33 % -79.53 % - -
1st Quarter March - - - -
FY (Year on Year)   - 23.32 % - -


Back to TPTX Growth rate Comparisons >> Back to TPTX Growth rate Comparisons >>


Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #268
Healthcare Sector #652
Overall #4040

Revenue Y/Y Growth Statistics
High Average Low
-97.7 % -98.05 % -98.3 %
(Jun 30 2022)   (Mar 31 2022)
Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #268
Healthcare Sector #652
Overall #4040
Revenue Y/Y Growth Statistics
High Average Low
-97.7 % -98.05 % -98.3 %
(Jun 30 2022)   (Mar 31 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Turning Point Therapeutics's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1.2075276500887E+16 % 2.4150553001773E+15 % -100 %
(Mar 31 2022)  


TPTX's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2022 Turning Point Therapeutics Inc. disclosed fall in Revenue from the first quarter by -72.33% to $ 0.12 millions, from $ 0.43 millions achived in the previous reporting period.

But that's not important problem, as Turning Point Therapeutics's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 177 other companies have achieved higher Revenue quarter on quarter growth. While Turning Point Therapeutics's Revenue growth quarter on quarter, overall rank is 3101.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #178
Healthcare Sector #506
Overall #3101
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #178
Healthcare Sector #506
Overall #3101
Revenue Q/Q Growth Statistics
High Average Low
1.2075276500887E+16 % 2.4150553001773E+15 % -100 %
(Mar 31 2022)  


TPTX's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2022 Turning Point Therapeutics Inc. disclosed fall in Revenue from the first quarter by -72.33% to $ 0.12 millions, from $ 0.43 millions achived in the previous reporting period.

But that's not important problem, as Turning Point Therapeutics's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 177 other companies have achieved higher Revenue quarter on quarter growth. While Turning Point Therapeutics's Revenue growth quarter on quarter, overall rank is 3101.


Turning Point Therapeutics's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)
Cumulative Revenue 12 Months Ending $ 1.01 $ 6.05 $ 30.83 $ 55.83 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -83.35 % -80.37 % -44.78 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 2972 # 3473 # 4001 # 0 # 0


Cumulative Revenue growth Comment


Turning Point Therapeutics Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 170
Sector # 492
S&P 500 # 2972
Cumulative Revenue growth Comment


Turning Point Therapeutics Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 170
Sector # 492
S&P 500 # 2972




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TPTX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2022
Edwards Lifesciences Corporation-0.15%$ -0.153 millions
Chemed Corporation-0.18%$ -0.182 millions
Heska Corporation-0.39%$ -0.387 millions
Ati Physical Therapy Inc -0.45%$ -0.451 millions
Phenomex Inc -0.52%$ -0.519 millions
Organon and Co -0.63%$ -0.627 millions
Outset Medical Inc -0.63%$ -0.631 millions
Accuray Incorporated-0.82%$ -0.823 millions
Travere Therapeutics Inc -0.82%$ -0.824 millions
Elite Pharmaceuticals Inc -0.84%$ -0.835 millions
Amedisys Inc-1.11%$ -1.112 millions
Teleflex Incorporated-1.25%$ -1.252 millions
Embecta Corp -1.32%$ -1.322 millions
Y mabs Therapeutics inc -1.41%$ -1.406 millions
Organogenesis Holdings Inc -1.46%$ -1.457 millions
10x Genomics Inc -1.67%$ -1.672 millions
Mimedx Group Inc -1.88%$ -1.881 millions
Acorda Therapeutics Inc -2.31%$ -2.309 millions
Community Health Systems Inc -2.43%$ -2.428 millions
Alpha Pro Tech Ltd -2.43%$ -2.432 millions
Advanced Container Technologies Inc -2.54%$ -2.539 millions
Kamada Ltd -2.68%$ -2.678 millions
Fresenius Medical Care Ag-2.73%$ -2.730 millions
Orthofix Medical Inc -2.74%$ -2.738 millions
3m Company-2.77%$ -2.771 millions
Teva Pharmaceutical Industries Limited-3.17%$ -3.171 millions
Neurometrix Inc -3.40%$ -3.397 millions
Royalty Pharma Plc-3.43%$ -3.425 millions
Bio rad Laboratories Inc -3.47%$ -3.468 millions
Healthlynked Corp-3.63%$ -3.630 millions


About Turning Point Therapeutics Revenue Growth Rates (TPTX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Turning Point Therapeutics Inc (CIK 1595893).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000950170-22-015542
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Turning Point Therapeutics Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.